Delivery Order SPE2DB24D8002-SPE2DB25FJNFK

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,461.21 Firm Fixed Price contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 14, 2023. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,601.22, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 19, 2023. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,776.14 firm fixed-price contract is for the delivery of the pharmaceutical product JARDIANCE 10 MG TABLET 90S. The contract has an ultimate completion date of May 30, 2024. Dakota Drug, Inc. is a key supplier for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $14,453.08 and an ultimate completion date of February 27, 2024. It is a firm fixed price, delivery order contract, and was not set aside for any specific socioeconomic program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Jardiance 25 mg tablets. The $18,252.90 firm fixed-price contract has an ultimate completion date of January 23, 2024. Dakota Drug, Inc. is an experienced federal contractor, holding a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,045.60, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a performance period extending through January 14, 2025. Dakota Drug, Inc. is a critical supplier for the DLA Troop Support Medical division, holding a significant $999,999,999.00 Indefinite Delivery Contract (IDC) as...
This is a $9,135.66 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication, to support the DLA Troop Support Medical's medical supply chain operations. This delivery order is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $27,657.68 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets over a performance period ending on November 20, 2024. The contract was not set aside for any specific business category. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,703.66, is for the delivery of 90 tablets of the pharmaceutical product Jardiance 10 mg. The contract has an ultimate completion date of July 16, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite Delivery Contract for a broad range of pharmaceutical products,...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,523.22 firm fixed-price contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product used to treat diabetes. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of medical products...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNFK
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,042.91, is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price, unrestricted delivery order with a period of performance through March 3, 2025.

Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which enables it to efficiently deliver critical medical items to various defense healthcare facilities.

Generated 5/30/25, 9:55 AM